259 related articles for article (PubMed ID: 20880784)
1. Imaging in clinical trials.
Murphy P; Koh DM
Cancer Imaging; 2010 Oct; 10 Spec no A(1A):S74-82. PubMed ID: 20880784
[TBL] [Abstract][Full Text] [Related]
2. Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy.
Desar IM; van Herpen CM; van Laarhoven HW; Barentsz JO; Oyen WJ; van der Graaf WT
Cancer Treat Rev; 2009 Jun; 35(4):309-21. PubMed ID: 19136215
[TBL] [Abstract][Full Text] [Related]
3. Quantitative imaging biomarkers in the clinical development of targeted therapeutics: current and future perspectives.
O'Connor JP; Jackson A; Asselin MC; Buckley DL; Parker GJ; Jayson GC
Lancet Oncol; 2008 Aug; 9(8):766-76. PubMed ID: 18672212
[TBL] [Abstract][Full Text] [Related]
4. Radiological evaluation of the therapeutic response of malignant diseases: status quo, innovative developments and requirements for radiology.
Höink AJ; Heindel W; Buerke B
Rofo; 2014 Oct; 186(10):927-36. PubMed ID: 25122173
[TBL] [Abstract][Full Text] [Related]
5. New approaches for imaging tumour responses to treatment.
Brindle K
Nat Rev Cancer; 2008 Feb; 8(2):94-107. PubMed ID: 18202697
[TBL] [Abstract][Full Text] [Related]
6. Functional imaging: what evidence is there for its utility in clinical trials of targeted therapies?
Tunariu N; Kaye SB; Desouza NM
Br J Cancer; 2012 Feb; 106(4):619-28. PubMed ID: 22281664
[TBL] [Abstract][Full Text] [Related]
7. Promise and pitfalls of quantitative imaging in oncology clinical trials.
Kurland BF; Gerstner ER; Mountz JM; Schwartz LH; Ryan CW; Graham MM; Buatti JM; Fennessy FM; Eikman EA; Kumar V; Forster KM; Wahl RL; Lieberman FS
Magn Reson Imaging; 2012 Nov; 30(9):1301-12. PubMed ID: 22898682
[TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer: the role of functional imaging as an end point in clinical trials.
Sala E; DeSouza N; Lee SI; Atri M; Hricak H;
Int J Gynecol Cancer; 2010 Aug; 20(6):971-8. PubMed ID: 20683404
[TBL] [Abstract][Full Text] [Related]
9. Oncologic imaging end-points for the assessment of therapy response.
Serkova NJ; Garg K; Bradshaw-Pierce EL
Recent Pat Anticancer Drug Discov; 2009 Jan; 4(1):36-53. PubMed ID: 19149687
[TBL] [Abstract][Full Text] [Related]
10. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
11. Considerations for generic oncology FDG-PET/CT protocol preparation in drug development.
Hallett WA; Maguire RP; McCarthy TJ; Schmidt ME; Young H
IDrugs; 2007 Nov; 10(11):791-6. PubMed ID: 17968761
[TBL] [Abstract][Full Text] [Related]
12. A review of diagnostic imaging in melanoma.
Dancey AL; Mahon BS; Rayatt SS
J Plast Reconstr Aesthet Surg; 2008 Nov; 61(11):1275-83. PubMed ID: 18694659
[TBL] [Abstract][Full Text] [Related]
13. Options for visualizing metastatic disease in the living body.
Helms MW; Brandt BH; Contag CH
Contrib Microbiol; 2006; 13():209-231. PubMed ID: 16627968
[TBL] [Abstract][Full Text] [Related]
14. The role of clinical imaging in oncological drug development.
Murphy PS; McCarthy TJ; Dzik-Jurasz AS
Br J Radiol; 2008 Sep; 81(969):685-92. PubMed ID: 18541632
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the technology for functional imaging in cancer.
Laking GR; Price PM; Sculpher MJ
Eur J Cancer; 2002 Nov; 38(16):2194-9. PubMed ID: 12387844
[TBL] [Abstract][Full Text] [Related]
16. Radiological diagnosis of hepatocellular carcinoma.
Saar B; Kellner-Weldon F
Liver Int; 2008 Feb; 28(2):189-99. PubMed ID: 18251978
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticles for imaging and tumor gene delivery.
Richard C; de Chermont Qle M; Scherman D
Tumori; 2008; 94(2):264-70. PubMed ID: 18564615
[TBL] [Abstract][Full Text] [Related]
18. The role of molecular imaging in drug discovery and development.
Hargreaves RJ
Clin Pharmacol Ther; 2008 Feb; 83(2):349-53. PubMed ID: 18167503
[TBL] [Abstract][Full Text] [Related]
19. Current developments and recent advances in musculoskeletal tumor imaging.
Kransdorf MJ; Bridges MD
Semin Musculoskelet Radiol; 2013 Apr; 17(2):145-55. PubMed ID: 23673546
[TBL] [Abstract][Full Text] [Related]
20. Standardising measurement of tumour vascularity by imaging: recommendations for ultrasound, computed tomography, magnetic resonance imaging and positron emission tomography.
Dixon AK; Gilbert FJ
Eur Radiol; 2012 Jul; 22(7):1427-9. PubMed ID: 22544291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
